These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 36745179)

  • 21. Neurobehavior of newborn infants exposed prenatally to methadone and identification of a neurobehavioral profile linked to poorer neurodevelopmental outcomes at age 24 months.
    Wouldes TA; Woodward LJ
    PLoS One; 2020; 15(10):e0240905. PubMed ID: 33064777
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neurodevelopmental Outcomes of Children Born to Opioid-Dependent Mothers: A Systematic Review and Meta-Analysis.
    Lee SJ; Bora S; Austin NC; Westerman A; Henderson JMT
    Acad Pediatr; 2020 Apr; 20(3):308-318. PubMed ID: 31734383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of neonatal outcomes in pregnant women undergoing medication-assisted treatment of opioid use disorder with methadone or buprenorphine/naloxone.
    Petrich M; Battin M; Walker E; Brown M; Abdelwahab M; Ma'ayeh M; Rood KM
    J Matern Fetal Neonatal Med; 2022 Dec; 35(26):10481-10486. PubMed ID: 36202398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neonatal neurobehavior effects following buprenorphine versus methadone exposure.
    Coyle MG; Salisbury AL; Lester BM; Jones HE; Lin H; Graf-Rohrmeister K; Fischer G
    Addiction; 2012 Nov; 107 Suppl 1(0 1):63-73. PubMed ID: 23106928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of maternal medication for opioid use disorder on neurodevelopmental outcomes of infants treated for neonatal opioid withdrawal syndrome.
    King RS; Peacock-Chambers E; Wilson D; Shimer J; Foss S; Visintainer P; Singh R
    J Neonatal Perinatal Med; 2021; 14(4):463-473. PubMed ID: 33843701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Women, Infants, and Opioids.
    Lowe NK
    J Obstet Gynecol Neonatal Nurs; 2017; 46(5):657-659. PubMed ID: 28802558
    [No Abstract]   [Full Text] [Related]  

  • 27. Severity of neonatal opioid withdrawal syndrome with prenatal exposure to serotonin reuptake inhibitors.
    Bakhireva LN; Sparks A; Herman M; Hund L; Ashley M; Salisbury A
    Pediatr Res; 2022 Mar; 91(4):867-873. PubMed ID: 34588611
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.
    Pryor JR; Maalouf FI; Krans EE; Schumacher RE; Cooper WO; Patrick SW
    Arch Dis Child Fetal Neonatal Ed; 2017 Mar; 102(2):F183-F187. PubMed ID: 28073819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired vision in children prenatally exposed to methadone: an observational cohort study.
    Hamilton R; Mulvihill A; Butler L; Chow A; Irving E; McCulloch DL; McNeil A; Michael K; Spowart KM; Waterson-Wilson J; Mactier H
    Eye (Lond); 2024 Jan; 38(1):118-126. PubMed ID: 37402864
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early Prediction Tool to Identify the Need for Pharmacotherapy in Infants at Risk of Neonatal Abstinence Syndrome.
    Isemann BT; Stoeckle EC; Taleghani AA; Mueller EW
    Pharmacotherapy; 2017 Jul; 37(7):840-848. PubMed ID: 28500629
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Are infants exposed to methadone in utero at an increased risk for mortality?
    Kelly LE; Rieder MJ; Bridgman-Acker K; Lauwers A; Madadi P; Koren G
    J Popul Ther Clin Pharmacol; 2012; 19(2):e160-5. PubMed ID: 22580362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Retrospective Cohort Study of Birth Outcomes in Neonates Exposed to Naltrexone in Utero: A Comparison with Methadone-, Buprenorphine- and Non-opioid-Exposed Neonates.
    Kelty E; Hulse G
    Drugs; 2017 Jul; 77(11):1211-1219. PubMed ID: 28536981
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neonatal abstinence syndrome.
    Coyle MG; Brogly SB; Ahmed MS; Patrick SW; Jones HE
    Nat Rev Dis Primers; 2018 Nov; 4(1):47. PubMed ID: 30467370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A review of the literature: How does prenatal opioid exposure impact placental health and fetal brain development?
    Humphries A; Simcox K; Howell B
    Dev Psychobiol; 2023 Apr; 65(3):e22378. PubMed ID: 36946682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of early developmental deficits in infants with prenatal heroin, methadone, and other opioid exposure.
    Beckwith AM; Burke SA
    Clin Pediatr (Phila); 2015 Apr; 54(4):328-35. PubMed ID: 25189695
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Developmental Outcomes after Opioid Exposure in the Fetus and Neonate.
    Fong J; Lewis J; Lam M; Kesavan K
    Neoreviews; 2024 Jun; 25(6):e325-e337. PubMed ID: 38821910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prenatal opioid exposure - Increasing evidence of harm.
    Mactier H; Hamilton R
    Early Hum Dev; 2020 Nov; 150():105188. PubMed ID: 32958331
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Methadone, Buprenorphine, and Naltrexone for the Treatment of Opioid Use Disorder in Pregnant Women.
    Tran TH; Griffin BL; Stone RH; Vest KM; Todd TJ
    Pharmacotherapy; 2017 Jul; 37(7):824-839. PubMed ID: 28543191
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.